遺伝子組換え技術の世界市場：製品タイプ別、用途別、エンドユーザー別、地域別

世界の遺伝子組換え技術の市場規模は、2025年には1,899億1,000万米ドルと推定され、2032年には3,656億2,000万米ドルに達すると予測され、2025年～2032年にCAGR9.8%で成長する見込みです。

図.遺伝子組換え技術市場シェア（%）、2025年、地域別

遺伝子組換え技術とは、2つの異なるソースからのDNA分子を結合して、自身の構成要素や関連タンパク質の複製や組み立てを指示できる1つの分子にすることです。 このプロセスには、制限酵素、DNAリガーゼ、逆転写酵素の使用を通じて、2つの異なるDNA鎖を物理的に結合させ、織り交ぜることが含まれます。最近の動向では、遺伝子組換え技術は遺伝学とバイオテクノロジーの分野において革命的な進歩を遂げ、医薬品開発、研究、農業など幅広い分野で応用されていることが証明されています。この技術により、ヒトのタンパク質や医薬品を従来の抽出法よりもはるかに大量に生産できるようになりました。また、現在不治の病の新たな治療法の開発や、農作物の収量向上にも利用されています。産業界全体で需要が拡大していることから、遺伝子組換え技術市場は今後数年で大きく成長する見通しです。

市場力学：

遺伝子組換え技術市場は、製薬およびバイオテクノロジー産業における研究開発活動の増加、慢性疾患の有病率の上昇、遺伝子工学および遺伝子治療に対する需要の高まりなど、いくつかの要因によって牽引されています。また、手ごろな価格の医療や治療ソリューションに対する需要と、DNA解析やシークエンシング技術の技術的進歩が相まって、市場の成長を後押ししています。しかし、開発に伴う高コストや臨床試験に対する厳しい規制により、市場の成長は制限される可能性があります。さらに、生殖細胞系列遺伝子編集に関する倫理的問題は、市場拡大の妨げとなる可能性があります。その反面、新興国における医療支出の増加は、主要企業に有利な機会を提供します。さらに、農業用途での遺伝子組換え作物の受け入れ拡大は、今後数年間で新たな収益ポケットを生み出すと予想されます。

本調査の主な特徴

• 本レポートでは、世界の遺伝子組換え技術市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模およびCAGR%を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 本レポートでは、企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の遺伝子組換え技術市場における主要企業プロファイルを掲載しています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプのアップグレード、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
• 世界の遺伝子組換え技術市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の遺伝子組換え技術市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 最近の動向
• 規制シナリオ
• 技術の進歩
• メーカー収益
• 買収と提携のシナリオ
• 製品の発売/承認
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の遺伝子組換え技術市場：COVID-19パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の遺伝子組換え技術市場：製品タイプ別（2020年～2032年）

• 組換えタンパク質医薬品
• ワクチン
• 遺伝子組換え作物
• 細胞および遺伝子治療
• 遺伝子編集

第6章 世界の遺伝子組換え技術市場：用途別（2020年～2032年）

• 治療
• 農業
• 研究
• その他

第7章 世界の遺伝子組換え技術市場：エンドユーザー別（2020年～2032年）

• バイオテクノロジーおよび製薬会社
• 診断検査室
• 学術機関および政府機関の研究所
• その他

第8章 世界の遺伝子組換え技術市場：地域別（2020年～2032年）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck &Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

第10章 アナリストの見解

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map（COM）

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Recombinant Dna Technology Market is estimated to be valued at USD 189.91 Bn in 2025 and is expected to reach USD 365.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Figure. Recombinant Dna Technology Market Share (%), By Region 2025

Recombinant DNA technology is the joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different strands of DNA through the use of restriction enzymes, DNA ligases and reverse transcriptase. In recent years, recombinant DNA technology has proven to be a revolutionary advancement in the field of genetics and biotechnology with wide ranging applications in drug development, research, and agriculture. This technology allows for the production of human proteins and medicines in much larger quantities than traditional extraction methods. It is also being used to develop new treatments for currently incurable diseases and to enhance crop yields. With growing demand across industries, the recombinant DNA technology market is poised to grow significantly in the coming years.

Market Dynamics:

The recombinant DNA technology market is driven by several factors such as increasing R&D activities in pharmaceutical and biotech industries, rising prevalence of chronic diseases, growing demand for genetic engineering, and gene therapy. The demand for affordable healthcare and therapeutic solutions combined with technological advancements in DNA analysis and sequencing techniques are also fueling the market growth. However, the market growth can be restricted due to high costs associated with development and stringent regulations for clinical trials. Moreover, ethical issues regarding germline gene editing may hamper market expansion to some extent. On the flip side, rising healthcare expenditures in emerging nations offer lucrative opportunities for key players. In addition, the growing acceptance of genetically modified crops for agriculture applications is expected to create new revenue pockets in the forthcoming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global recombinant DNA technology market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global recombinant DNA technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi , Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company, Genentech Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., GSK plc., Jiangsu Recbio Technology Co., Ltd., New England Biolabs, GenScript, Lonza, and ProteoGenix.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global recombinant DNA technology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant DNA technology market.

Detailed Segmentation-

• By Product Type:
  • Recombinant Protein Drugs
  • Vaccines
  • Genetically Modified Crops
  • Cell and Gene Therapy
  • Gene Editing
• By Application:
  • Therapeutics
  • Agriculture
  • Research
  • Others
• By End User:
  • Biotechnology and Pharmaceutical Company
  • Diagnostic Laboratories
  • Academic and Government Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Biogen, Inc.
  • Sanofi
  • Pfizer, Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Regulatory Scenario
• Technological Advancements
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Recombinant DNA Technology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Recombinant DNA Technology Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Recombinant Protein Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetically Modified Crops
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell and Gene Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Editing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Recombinant DNA Technology Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Agriculture
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Recombinant DNA Technology Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Company
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Government Laboratories
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Recombinant DNA Technology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Biogen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Profacgen
  • Monsanto Company
  • Genentech Inc.
  • Eli Lilly and Company
  • Janssen Pharmaceuticals Inc.
  • GSK plc.
  • Jiangsu Recbio Technology Co., Ltd.
  • New England Biolabs
  • GenScript
  • Lonza
  • ProteoGenix

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"